Europe’s Divisional Patent Trap: How Big Pharma Delays Generics Without Ever Losing in Court
Europe’s “divisional patent” trap is one of those mechanisms that sounds technical—until you see what it does to patients, payers, and timelines.
Here’s the hook: Big Pharma can often delay generic entry in Europe without ever “losing” in court.
That’s…
